Use of Monsel solution to treat obstetrical hemorrhage: a review and comparison to other topical hemostatic agents

Peripartum hemorrhage accounts for 8% of maternal deaths in the United States, and nearly 27% worldwide. A growing need exists for tactics to spare morbidity given a rise of abnormal placentation that contributes to excessive blood loss at the time of delivery. Approaches such as compression sutures...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	American journal of obstetrics and gynecology 2015-06, Vol.212 (6), p.725-735
Hauptverfasser:	Miller, Devin T., MD, Roque, Dana M., MD, Santin, Alessandro D., MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Female Ferric Compounds - therapeutic use hemostatic agent Hemostatics - therapeutic use Humans Monsel solution Obstetrics and Gynecology peripartum hemorrhage placenta accrete Postpartum Hemorrhage - drug therapy Pregnancy Sulfates - therapeutic use Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!